Results 1 to 10 of about 229,168 (314)

Advancing anticoagulation stewardship: A call to action for stewardship from the US-based anticoagulation forum

Thrombosis Update, 2022
Purpose: Anticoagulation Stewardship is urgently needed to improve anticoagulation management and bend the current, negative trajectory on anticoagulation-related harm.
Allison Burnett, Kelly M. Rudd, Darren Triller   +2 more
doaj   +1 more source

Social App to Improve Warfarin Therapy in Post-MHVR Chinese Patients: A Randomized Controlled Trial

Cardiovascular Therapeutics, 2023
Background. Poor anticoagulation quality was a major problem among warfarin-treated patients, which called for innovative and effective methods to improve it. Objective.
Litao Zhang, Sha Li, Zishuo Li, Dan Yu, Haiyan Wu, Bing Hua, Li Xie, Xia Yuan, Yun Li, Zhenlu Zhang, Yanli Long   +10 more
doaj   +1 more source

Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score

Bleeding, Thrombosis and Vascular Biology, 2023
Not ...
Paolo Prandoni
doaj   +1 more source

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants

Research and Practice in Thrombosis and Haemostasis, 2022
Lupus anticoagulants (LA) are one laboratory criterion for classification of antiphospholipid syndrome, with presence of vascular thrombosis and/or pregnancy/fetal morbidity being clinical criteria. The presence of LA is detected (or excluded) by laboratory testing, with the activated partial thromboplastin time and dilute Russell's viper venom time ...
Emmanuel J. Favaloro, Leonardo Pasalic
openaire   +3 more sources

A re-appraisal of thrombogenesis in COVID-19, seen as a multiple "Complex system"

Bleeding, Thrombosis and Vascular Biology, 2022
The aim of this essay is to re-consider the peculiar type of thrombogenesis observed in severe cases of COVID-19 infection, focusing on the multiple interconnected networks involved, such as inflammation, blood coagulation, fibrinolysis, and immune ...
Sergio Coccheri
doaj   +1 more source

Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

Bleeding, Thrombosis and Vascular Biology, 2023
The definite diagnosis of antiphospholipid syndrome (APS) depends on the laboratory performance and clinicians’ interpretation. Results from two Italian inception cohort studies of anti-phospholipid antibodies (aPL)-positive subjects, the Italian Survey
Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators   +11 more
doaj   +1 more source

Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

Bleeding, Thrombosis and Vascular Biology, 2022
The year 1222 has traditionally been accepted as the University of Padua’s founding date. The University of Padua is a prestigious center for learning and research, and over the centuries, it has produced luminaries in the most significant disciplines ...
Paolo Simioni, Vittorio Pengo, Paolo Prandoni   +2 more
doaj   +1 more source

Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review

Research and Practice in Thrombosis and Haemostasis, 2021
Introduction Postthrombotic syndrome (PTS) is a form of secondary chronic venous insufficiency (CVI) that occurs after deep vein thrombosis (DVT). Effective treatments for PTS are lacking.
Ke Xuan Li, Gisele Diendéré, Jean‐Philippe Galanaud, Nada Mahjoub, Susan R. Kahn   +4 more
doaj   +1 more source

Framework Development for Clinical Comprehensive Evaluation of Drugs–a Study Protocol Using the Delphi Method and Analytic Hierarchy Process

Frontiers in Pharmacology, 2022
Measuring the value of drugs to help make health-care decisions is a complex process which involves confronting trade-offs among multiple objectives. Although guidelines have been released for clinical comprehensive evaluation of drugs, refinement is ...
Chi Zhang, Chi Zhang, Chi Zhang, Er-Li Ma, Bing-Long Liu, Bin Wu, Zhi-Chun Gu, Zhi-Chun Gu, Hou-Wen Lin, Hou-Wen Lin, Hou-Wen Lin   +10 more
doaj   +1 more source

Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real-World Setting

Frontiers in Cardiovascular Medicine, 2021
Background: In the clinical setting, the economic benefits of direct oral anticoagulants (DOACs) in elderly patients with atrial fibrillation (AF) remain unclear.
Yue Wu, Yue Wu, Chi Zhang, Chi Zhang, Chi Zhang, Zhi-Chun Gu, Zhi-Chun Gu, Zhi-Chun Gu   +7 more
doaj   +1 more source